Not applicableLooking for participantsNCT05152238What this trial is testingITP Registry and Accompanying Biospecimen CollectionWho this might be right forImmune Thrombocytopenia Jena University Hospital 1,100
Not applicableNo Longer AvailableNCT03363334What this trial is testingExpanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITPWho this might be right forImmune Thrombocytopenic Purpura Rigel Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT00251277What this trial is testingUse of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic PurpuraWho this might be right forThrombotic Thrombocytopenic Purpura Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Looking for participantsNCT06992128What this trial is testingRomiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional TrialWho this might be right forPrimary Immune Thrombocytopenia (ITP) Institute of Hematology & Blood Diseases Hospital, China 129
Large-scale testing (Phase 3)Study completedNCT05438875What this trial is testingThe Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9Who this might be right forPurpura, Thrombocytopenic, Idiopathic Peking University People's Hospital 96
Large-scale testing (Phase 3)Study completedNCT00504075What this trial is testingFind How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)Who this might be right forChronic Idiopathic Thrombocytopenic Purpura Bio Products Laboratory 35
Very early researchUnknownNCT06417398What this trial is testingPreliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis+4 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Not applicableNot Yet RecruitingNCT07426107What this trial is testingDevelopment and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary RevascularizationWho this might be right forImmune Thrombocytopenic PurpuraCoronary Artery Disease Xiao Hui Zhang 600
Not applicableLooking for participantsNCT06817395What this trial is testingCognitive Dysfunction in Chronic and Persistent Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Massachusetts General Hospital 100
Not applicableEnded earlyNCT01938404What this trial is testingOctaplas Adult TTP TrialWho this might be right forThrombotic Thrombocytopenic Purpura Octapharma 1
Large-scale testing (Phase 3)Not Yet RecruitingNCT07455006What this trial is testingSafety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric PatientsWho this might be right forThrombocytopenia, Immune Qilu Pharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)WithdrawnNCT01609452What this trial is testingMONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITPWho this might be right forImmune Thrombocytopenic PurpuraIdiopathic Thrombocytopenic Purpura Anthera Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01520909What this trial is testingStudy of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.Who this might be right forIdiopathic Thrombocytopenic Purpura GlaxoSmithKline 92
Not applicableStudy completedNCT00861224What this trial is testingEffects of Long-term Dosing of AMG 531 on Bone Marrow MorphologyWho this might be right forIdiopathic Thrombocytopenic Purpura Amgen 10
Testing effectiveness (Phase 2)WithdrawnNCT05509582What this trial is testingExtension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated CytopeniasWho this might be right forImmune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD National Heart, Lung, and Blood Institute (NHLBI)
Large-scale testing (Phase 3)Study completedNCT00344149What this trial is testingRituximab as Second Line Treatment for ITPWho this might be right forImmune Thrombocytopenia (ITP) Ostfold Hospital Trust 112
Not applicableStudy completedNCT07805408What this trial is testingA Real World Study of Treatment Patterns and Effectiveness of Standard of Care in Primary Immune Thrombocytopenia PatientsWho this might be right forImmune Thrombocytopenia Novartis Pharmaceuticals 3,714
Not applicableStudy completedNCT01439321What this trial is testingOutcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and RomiplostimWho this might be right forImmune Thrombocytopenic Purpura GlaxoSmithKline 280
Not applicableStudy completedNCT03421392What this trial is testingStudy of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICTWho this might be right forIdiopathic Thrombocytopenic Purpura Nantes University Hospital 40
Not applicableStudy completedNCT01931644What this trial is testingAt-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsWho this might be right forAll Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more Sanguine Biosciences 17,667